Semaglutide linked to lower bone fracture risk
.jpg&w=3840&q=75)
A study suggests that the medication semaglutide may be associated with a reduced risk of bone fractures. The report is published by the Endocrine Society as part of their ongoing medical research and clinical practice updates.
Why it matters
This finding could influence clinical treatment protocols for patients using GLP-1 receptor agonists.
News Advocacy Awards Endocrine Topics Education & Training Practice Guidelines Journals Meetings & Events Store Hello, Please login Your Account & Tools Learning Claim credits Plan your learning Browse journals and articles View sessions recordings Membership Renew membership Submit Your Science! Find other members Career Get published Earn recognition Develop your career Promote your work Join Login 0 Items Menu Login Sign Up The Latest Our Community Open Submenu Special Interest Groups Career & Professional Development EndoCareers Community & Global Exchange Expanding Field of Endocrinology About Endocrine Society Find an Endocrinologist Advancing Research Open Submenu Scientific Statements Research Opportunities Stay Informed: Scientific Journals Research Fellowships & Programs Research Awards Improving Practice Open Submenu Clinical Practice Guidelines Education & Training Physician Payment: QPP and MACRA Membership Open Submenu Member Rates Renew Membership Member Resources EndoForum Get Involved Membership Toolkit Partnerships Open Submenu Corporate Liaison Board ENDO 2026 Satellite Symposia Guidelines.pdf Advertise With Us JOIN OR RENEW TODAY! News Advocacy Awards Endocrine Topics Education & Training Practice Guidelines Journals Meetings & Events Store JOIN OR RENEW TODAY! Close The Latest Our Community Open Submenu Special Interest Groups Career & Professional Development EndoCareers Community & Global Exchange Expanding Field of Endocrinology About Endocrine Society Find an Endocrinologist Advancing Research Open Submenu Scientific Statements Research Opportunities Stay Informed: Scientific Journals Research Fellowships & Programs Research Awards Improving Practice Open Submenu Clinical Practice Guidelines Education & Training Physician Payment: QPP and MACRA Membership Open Submenu Member Rates Renew Membership Member Resources EndoForum Get Involved Membership Toolkit Partnerships Open Submenu Corporate Liaison Board ENDO 2026 Satellite Symposia Guidelines.pdf Advertise With Us JOIN OR RENEW TODAY! Endocrine News News Room Semaglutide linked to lower bone fracture risk SHARE email facebook twitter bluesky pinterest print Press Release Meetings & Events Semaglutide linked to lower bone fracture risk Chicago, IL June 14, 2026 Bone health study compared GLP-1 to other anti-obesity medications
The content is a professional medical society announcement regarding research findings.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in